Medical Advisor - 14+ vagas

Novartis

**Summary**: LI-Hybrid Supervisiona a execução e interpretação de pesquisas de ensaios clínicos, atividades de coleta de dados e operações clínicas. Estabelece e aprova métodos científicos para o desenho e implementação de protocolos clínicos, sistemas de coleta de dados e relatórios finais. Auxilia

Syneos Health, Inc.

Updated: February 12, **** Location: Natal, Brazil Job ID: *****-OTHLOC-Cf3KYfwK Our client is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) Inhibitors desig

Syneos Health, Inc.

Updated: February 12, 2026 Location: Natal, Brazil Job ID: 13988-OTHLOC-Cf3KYfwK Our client is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS‑addicted cancers. The company’s R&D pipeline comprises RAS(ON) Inhibitors desig

Syneos Health, Inc.

Updated: February 12, ****Location: Natal, BrazilJob ID:*****-OTHLOC-Cf3KYfwK Our client is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) Inhibitors designed

Syneos Health, Inc.

Our client is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inh

Syneos Health, Inc.

Updated: Yesterday Location: Sao Paulo, Brazil Job ID: 13988 Our client is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS‑addicted cancers. The company’s R&D pipeline comprises RAS(ON) Inhibitors designed to suppress dive

Y-Axis

Lead Field Medical Advisor - Remote at Jobgether Job type: Full Time Start date: Immediate Remote: Yes Telecommute: Yes Sponsor visa: No Experience: 5 year(s) or above Skills: Medical Expertise, Scientific Exchange, Presentation Skills, Strategic Engagement, Project Management, Collaboration, Commun

Our client is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inh

Our client is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inh

Y-Axis

Lead Field Medical Advisor - Remote at Jobgether Job type: Full Time Start date: Immediate Remote: Yes Telecommute: Yes Sponsor visa: No Experience: 5 year(s) or above Skills: Medical Expertise, Scientific Exchange, Presentation Skills, Strategic Engagement, Project Management, Collaboration, Commun

Lead Field Medical Advisor - Remote at Jobgether Job type: Full Time Start date: Immediate Remote: Yes Telecommute: Yes Sponsor visa: No Experience: 5 year(s) or above Skills: Medical Expertise, Scientific Exchange, Presentation Skills, Strategic Engagement, Project Management, Collaboration, Commun

Updated: February 12, 2026 Location: Natal, Brazil Job ID: 13988-OTHLOC-Cf3KYfwK Our client is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS‑addicted cancers. The company’s R&D pipeline comprises RAS(ON) Inhibitors desig

Updated: Yesterday Location: Sao Paulo, Brazil Job ID: 13988 Our client is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS‑addicted cancers. The company’s R&D pipeline comprises RAS(ON) Inhibitors designed to suppress dive

Our client is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inh